Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Harvard University
- Nanyang Technological University
- University of British Columbia
- University of Maryland, Baltimore
- City of Hope
- Cold Spring Harbor Laboratory
- Francis Crick Institute
- Monash University
- UNIVERSITY OF SOUTHAMPTON
- ADELAIDE UNIVERSITY
- Cold Spring Harbor Laboratory (CSHL)
- Dana-Farber Cancer Institute (DFCI)
- Dartmouth College
- Indiana University
- Johns Hopkins Medicine - Laboratory of Human Biomimetics
- MONASH UNIVERSITY
- NTNU - Norwegian University of Science and Technology
- National University of Singapore
- SUNY University at Buffalo
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- UCL;
- Universidade de Coimbra
- Universidade do Minho
- University College London (UCL)
- University of California, Los Angeles
- University of Michigan
- eQuest
- 17 more »
- « less
-
Field
-
and metabolism influence cellular networks that govern tissue regeneration, cancer and immunity. We dissect the precise mechanisms of how reciprocal interactions between tissue stem cells; immune cells
-
constructs, to study neural network dynamics, disease mechanisms, or drug response using in vitro or ex vivo systems. The candidate will collaborate with neuroscientists, stem cell researchers, and
-
in a PhD. Requirement for granting the fellowship: The applicants may apply without prior registration in the course for which the fellowship is open. The requirement to enroll in a degree course will
-
candidate will have a PhD in molecular biology, neuroscience, or a related discipline and will have experience in the culture of human pluripotent stem cells, genome editing, and/or single-cell genomics. UMB
-
enhanced-mesenchymal stem/stromal cells (MSC) therapeutic strategies for the treatment of liver inflammation during chronic injury and hepatogenous diabetes with special emphasis on cytokine secretion and
-
systems, including induced pluripotent stem cells (iPSCs) and conditional gene knockouts will be used in these research projects. Many state-of-the-art techniques are employed, such as CRISPR/Cas9 Genome